Literature DB >> 24390935

Split-Cre recombinase effectively monitors protein-protein interactions in living bacteria.

Sean P O'Brien1, Matthew P DeLisa.   

Abstract

The ability of Cre recombinase to excise genetic material has been used extensively for genome engineering in prokaryotic and eukaryotic cells. Recently, split-Cre fragments have been described that advance control of recombinase activity in mammalian cells. However, whether these fragments can be utilized for monitoring protein-protein interactions has not been reported. In this work, we developed a protein-fragment complementation assay (PCA) based on split-Cre for monitoring and engineering pairwise protein interactions in living Escherichia coli cells. This required creation of a dual-fluorescent reporter plasmid that permits visualization of reconstituted Cre recombinase activity by switching from red to green in the presence of an interacting protein pair. The resulting split-Cre PCA faithfully links cell fluorescence with differences in binding affinity, thereby allowing the facile isolation of high-affinity binders based on phenotype. Given the resolution of its activity and sensitivity to interactions, our system may prove a viable option for poorly expressed or weakly interacting protein pairs that evade detection in other PCA formats. Based on these findings, we anticipate that our split-Cre PCA will become a highly complementary and useful new addition to the protein-protein interaction toolbox.
Copyright © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Escherichia coli; Fluorescent proteins; Pairwise protein interactions; Protein engineering; Protein-complementation assay

Mesh:

Substances:

Year:  2014        PMID: 24390935     DOI: 10.1002/biot.201300462

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  1 in total

1.  Light-Inducible Recombinases for Bacterial Optogenetics.

Authors:  Michael B Sheets; Wilson W Wong; Mary J Dunlop
Journal:  ACS Synth Biol       Date:  2020-01-21       Impact factor: 5.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.